Study of pathomechanism, prediction and bio-marker for severe cutaneous adverse reaction

Study of pathomechanism, prediction and bio-marker for severe cutaneous adverse reaction - Study of pathomechanism, prediction and bio-marker for severe cutaneous adverse reaction

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009453

Enrollment

Registered

2012-12-01

Start date

2012-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe cutaneous adverse reaction

Interventions

Collection of 5ml peripheral blood and 2 pieces of skin biopsies

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Severe cutaneous adverse reaction patient who agreed informed consent

Exclusion criteria

Exclusion criteria: patient who is recognized as inadequate for joining this study by principal investigator

Design outcomes

Primary

Measure	Time frame
Identification of bio-marker for severe cutaneous adverse reaction	—

Countries

Japan

Contacts

Public ContactHiroaki Azukizawa

Osaka University,Graduate School of Medicine Department of Dermatology

azukizaw@derma.med.osaka-u.ac.jp06-6879-3031

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026